Abstract Submission Categories & Descriptions

Please familiarize yourself with the below categories. Selecting the correct category aids the review process.

1. Carbon-11 Radiochemistry

This category welcomes scientific contributions related to the development and utility of Carbon-11 radiochemistry advancements. Topics may include the design and radiosynthesis of ¹¹C-labelled radiotracers, reagents, and synthons and the development of novel Carbon-11 radiosynthetic methods and strategies.

2. Fluorine-18 Radiochemistry

This category welcomes scientific contributions related to the development and utility of Fluorine-18 radiochemistry advancements. Topics may include the design and synthesis of ¹⁸F-labeled radiotracers or reagents, the development of novel Fluorine-18 chemical methods as well as bioconjugation strategies or similar concepts within the ¹⁸F chemistry domain.

3. Radiometal & Chelator Chemistry

This category welcomes scientific contributions that cover the broad domains of radiometal ion complexation chemistry, ligand design, synthesis, and characterization, as well as the development or application of state-of-the-art bioconjugation methods involving radiometals.

4. Chemistry of Other Radioisotopes

This category welcomes scientific contributions that cover chemistry related to radioisotopes other than ¹¹C, ¹⁸F, and radiometals. Topics may include the design and synthesis of radiotracers or radiolabeled synthons as well as development or application of bioconjugation methods. 

5. Imaging Applications of Radiolabeled Compounds in Oncology

This category welcomes scientific contributions that cover In vitro and in vivo experimental evaluation of new radiolabeled compounds for imaging tumors including preliminary clinical studies and basic research on novel diagnostic applications in oncology using known labeled compounds.

6. Radionuclide Therapy 

This category welcomes scientific contributions that cover the preparation, characterization, and in vitro and in vivo evaluation of radionuclides and radiolabeled compounds for the treatment of the spectrum of different diseases including preclinical and clinical studies.

7. Applications of Radiolabeled Compounds in Neuroscience

This category welcomes scientific contributions that cover in vitro and in vivo experimental evaluation of new radiolabeled compounds for imaging brain chemistry and function including preliminary clinical studies and basic research on novel diagnostic applications in Neurology using known labeled compounds.

8. Applications of Radiolabeled Compounds in Other Fields

This category welcomes scientific contributions that cover in vitro and in vivo experimental evaluation of new radiolabeled compounds for imaging other than neurologic and oncologic applications, such as agents for cardiovascular, infection, inflammation, etc. Preliminary clinical studies and basic research on novel diagnostic applications in these fields using known labeled compounds fall into this category.

9. Radiopharmaceutical Technologies

This category welcomes scientific contributions related to all the technological innovations that support the translation of basic radiochemical discoveries into practice. This includes advancements in Automation, Microfluidics, Process Development, Green Radiochemistry, and similarly related strategies and customizations.

10. Multimodality Imaging Probes or Techniques

This category welcomes scientific contributions that cover design, chemistry, labeling strategies, and applications of multimodal imaging probes. This includes approaches to implement multimodality imaging techniques: e.g. monomolecular probe, sequential or cocktail injection of biomarkers, and combining two or more imaging modalities (PET/SPECT, optical imaging, MRI and ultrasound, etc.)

11. Nanomedicine and New Biological Vectors

This category welcomes scientific contributions related to the development and application of radiolabeled nanomaterials and natural or engineered biological vectors. This includes the design, synthesis, labeling strategies, and preclinical or early clinical application of nanomedicines and biological vectors.  

12. Radiopharmacy

This category welcomes scientific contributions related to radiosynthesis optimization of known radiotracers, adaptation of radiosynthetic methods to regulatory compliance for patient use, their good manufacturing production, improvement in radioanalytical methods and compounding of radiopharmaceuticals for routine clinical use, and related topics.

13. Targetry 

This category welcomes scientific contributions related to cyclotron, reactor or linac isotope production, targetry, and purification chemistry.

14. Theranostics 

This category welcomes scientific contributions that cover the integration of diagnosis and treatment, as well as image-guided therapies, such as radiotherapy, chemotherapy, and immunotherapy, to predict response or improve treatment effectiveness.

15. Artificial Intelligence and Computational Chemistry 

This category welcomes scientific contributions related to all aspects of computational chemistry to calculate or support radiotracer design and development. Artificial intelligence applications in radiochemistry involving big data and machine learning tools for detection of molecular properties (e.g. pharmacophores), predictive analysis (e.g. molecular docking), as well as design and discovery of radiotracers and targets fall into this category.